BNP Paribas Financial Markets’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.9M Buy
343,279
+212,502
+162% +$11.7M 0.01% 815
2025
Q1
$9.24M Sell
130,777
-16,360
-11% -$1.16M 0.01% 1017
2024
Q4
$9.67M Sell
147,137
-3,227
-2% -$212K 0.01% 948
2024
Q3
$10.6M Buy
150,364
+17,010
+13% +$1.2M 0.01% 782
2024
Q2
$11M Sell
133,354
-79,083
-37% -$6.51M 0.01% 751
2024
Q1
$18.6M Sell
212,437
-127,794
-38% -$11.2M 0.02% 596
2023
Q4
$32.8M Buy
340,231
+162,768
+92% +$15.7M 0.04% 342
2023
Q3
$15.7M Sell
177,463
-48,644
-22% -$4.3M 0.02% 479
2023
Q2
$19.6M Sell
226,107
-14,260
-6% -$1.24M 0.02% 451
2023
Q1
$23.4M Buy
240,367
+8,530
+4% +$829K 0.03% 364
2022
Q4
$24M Buy
+231,837
New +$24M 0.04% 384
2022
Q3
Sell
-195,856
Closed -$16.2M 4035
2022
Q2
$16.2M Buy
195,856
+7,868
+4% +$652K 0.03% 462
2022
Q1
$14.5M Buy
187,988
+54,556
+41% +$4.21M 0.02% 517
2021
Q4
$11.8M Buy
133,432
+59,621
+81% +$5.27M 0.02% 607
2021
Q3
$5.7M Buy
73,811
+10,192
+16% +$788K 0.01% 875
2021
Q2
$5.31M Sell
63,619
-9,184
-13% -$766K 0.01% 914
2021
Q1
$5.5M Sell
72,803
-74,414
-51% -$5.62M 0.01% 829
2020
Q4
$12.9M Sell
147,217
-22,666
-13% -$1.99M 0.02% 442
2020
Q3
$12.9M Sell
169,883
-45,435
-21% -$3.46M 0.02% 471
2020
Q2
$26.6M Buy
215,318
+69,490
+48% +$8.57M 0.05% 251
2020
Q1
$12.3M Sell
145,828
-22,257
-13% -$1.88M 0.03% 408
2019
Q4
$14.2M Buy
168,085
+67,919
+68% +$5.74M 0.03% 400
2019
Q3
$6.75M Sell
100,166
-47,949
-32% -$3.23M 0.01% 625
2019
Q2
$12.7M Buy
148,115
+63,259
+75% +$5.42M 0.03% 393
2019
Q1
$7.54M Buy
84,856
+40,187
+90% +$3.57M 0.02% 541
2018
Q4
$3.8M Sell
44,669
-105,895
-70% -$9.02M 0.01% 651
2018
Q3
$14.6M Buy
150,564
+67,495
+81% +$6.54M 0.02% 453
2018
Q2
$7.83M Sell
83,069
-13,953
-14% -$1.31M 0.01% 611
2018
Q1
$7.87M Buy
97,022
+20,242
+26% +$1.64M 0.01% 544
2017
Q4
$6.85M Buy
76,780
+21,259
+38% +$1.9M 0.01% 550
2017
Q3
$5.17M Buy
55,521
+34,430
+163% +$3.2M 0.01% 737
2017
Q2
$1.92M Sell
21,091
-25,625
-55% -$2.33M 0.01% 1083
2017
Q1
$4.1M Buy
46,716
+13,051
+39% +$1.15M 0.01% 761
2016
Q4
$2.79M Sell
33,665
-66,083
-66% -$5.47M 0.01% 702
2016
Q3
$9.23M Buy
99,748
+76,885
+336% +$7.11M 0.04% 315
2016
Q2
$1.78M Sell
22,863
-33,607
-60% -$2.61M 0.01% 916
2016
Q1
$4.66M Sell
56,470
-24,731
-30% -$2.04M 0.02% 585
2015
Q4
$8.51M Sell
81,201
-49,265
-38% -$5.16M 0.02% 496
2015
Q3
$13.7M Buy
130,466
+20,524
+19% +$2.16M 0.03% 332
2015
Q2
$15M Sell
109,942
-32,348
-23% -$4.42M 0.04% 244
2015
Q1
$17.7M Buy
142,290
+136,334
+2,289% +$17M 0.05% 246
2014
Q4
$538K Sell
5,956
-2,344
-28% -$212K ﹤0.01% 1104
2014
Q3
$599K Sell
8,300
-2,316
-22% -$167K ﹤0.01% 1276
2014
Q2
$660K Sell
10,616
-2,931,071
-100% -$182M ﹤0.01% 1180
2014
Q1
$302M Buy
2,941,687
+2,928,798
+22,723% +$301M 0.23% 67
2013
Q4
$906K Sell
12,889
-26,057
-67% -$1.83M ﹤0.01% 947
2013
Q3
$2.81M Buy
38,946
+25,116
+182% +$1.81M ﹤0.01% 763
2013
Q2
$772K Buy
+13,830
New +$772K ﹤0.01% 1008